Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Revenue (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Revenue data on record, last reported at $13.3 million in Q3 2025.

  • For Q3 2025, Revenue rose 40.23% year-over-year to $13.3 million; the TTM value through Sep 2025 reached $27.1 million, down 72.43%, while the annual FY2024 figure was $90.7 million, N/A changed from the prior year.
  • Revenue reached $13.3 million in Q3 2025 per GOSS's latest filing, up from $11.5 million in the prior quarter.
  • Across five years, Revenue topped out at $88.8 million in Q2 2024 and bottomed at -$7.6 million in Q4 2024.
  • Average Revenue over 4 years is $8.7 million, with a median of -$3.4 million recorded in 2022.
  • Peak YoY movement for Revenue: soared 383.58% in 2024, then plummeted 87.06% in 2025.
  • A 4-year view of Revenue shows it stood at -$3.5 million in 2022, then grew by 3.3% to -$3.3 million in 2023, then crashed by 126.74% to -$7.6 million in 2024, then surged by 275.38% to $13.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were $13.3 million in Q3 2025, $11.5 million in Q2 2025, and $9.9 million in Q1 2025.